Pharmaceutical Technology Europe-07-01-2007

Pharmaceutical Technology Europe

Profiling biopharma medicines

July 01, 2007

Biopharmaceuticals

19

7

... the biotech industry could make characterization of its products easier by paying more attention to downstream processing and purification issues, creating a cleaner product that is easier to identify.

FDA's new guidance for industry

July 01, 2007

News

19

7

Anyone familiar with the USA v Barr Laboratories case of 1993 will recognize the importance of not ignoring OOS results, and the inappropriateness of testing into compliance.